• May reduce mortality though only with certain causative organisms:
    • Significant reduction in death seen in patients with streptococcus pneumoniae meningitis (29.9% versus 36.0%),
    • Not significantly reduced in all-cause meningitis (17.8% versus 19.9%)
  • May improve long-term outcome in survivors:
    • Significantly reduction in hearing loss (13.8% versus 19.0%)
    • Significantly reduction in neurological sequelae (17.9% versus 21.6%).